| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5119c6ebde4a82b3f8dc3a64612901c9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2015-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_580e8ed53e3fe412a5313d7c238f8866 |
| publicationDate |
2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-105017170-A |
| titleOfInvention |
A class of cyanobenzotriazole sulfoxide 11β-HSD1 inhibitors and uses thereof |
| abstract |
The invention relates to the field of medicine related to type 2 diabetes. Specifically, the present invention relates to a class of 11β-HSD1 inhibitors containing nitrile phenyltriazole sulfoxide structure, its preparation method and its application in the preparation of type 2 diabetes drugs. |
| priorityDate |
2015-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |